SNCA and Parkinson disease: The above literature data on changes in the metabolism of α-synuclein in nigrostriatal dopaminergic neurons and changes in the content of α-synuclein in the blood prompted us to compare the concentrations of α-synucleins in the blood of patients at risk of developing PD with patients in the control.